State Street Corp Neurocrine Biosciences Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 5,148,293 shares of NBIX stock, worth $647 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,148,293

Previous 4,608,357 11.72%

Holding current value

$647 Million

Previous $634 Million 6.57%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $61.9 Million - $82.7 Million	539,936 Added 11.72%	5,148,293 $593 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $80.9 Million - $88.5 Million	618,396 Added 15.5%	4,608,357 $634 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $9.57 Million - $10.5 Million	-73,375 Reduced 1.81%	3,989,961 $550 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $24.1 Million - $30.1 Million	226,829 Added 5.91%	4,063,336 $535 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $11.3 Million - $14.1 Million	-119,992 Reduced 3.03%	3,836,507 $432 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $14 Million - $16.4 Million	156,584 Added 4.12%	3,956,499 $373 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $6.56 Million - $8.58 Million	69,729 Added 1.87%	3,799,915 $385 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $3.9 Million - $4.64 Million	-36,535 Reduced 0.97%	3,730,186 $446 Million
Q3 2022 Nov 15, 2022	SELL	$92.03 - $107.81 $546,566 - $640,283	-5,939 Reduced 0.16%	3,766,721 $400 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $2.92 Million - $3.85 Million	38,490 Added 1.03%	3,772,660 $368 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $509,251 - $666,419	7,029 Added 0.19%	3,734,170 $350 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $21.2 Million - $28.3 Million	266,073 Added 7.69%	3,727,141 $317 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $4.11 Million - $4.73 Million	47,735 Added 1.4%	3,461,068 $332 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $13.1 Million - $14.9 Million	145,990 Added 4.47%	3,413,333 $332 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $69.2 Million - $94.3 Million	790,012 Added 31.89%	3,267,343 $318 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $17.4 Million - $21.7 Million	199,942 Added 8.78%	2,477,331 $237 Million
Q3 2020 Nov 10, 2020	SELL	$96.16 - $135.15 $1.02 Million - $1.44 Million	-10,651 Reduced 0.47%	2,277,389 $219 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $19 Million - $29.1 Million	-223,221 Reduced 8.89%	2,288,040 $279 Million
Q1 2020 May 11, 2020	BUY	$75.11 - $113.76 $189 Million - $286 Million	2,511,261 New	2,511,261 $217 Million

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Neurocrine Biosciences Inc Transaction History